1,026
Views
154
CrossRef citations to date
0
Altmetric
Review

Nanotechnology-based drug delivery systems for control of microbial biofilms: a review

, , , , , , , & show all
Pages 1179-1213 | Published online: 27 Feb 2018

References

  • LeventhalGEHillALNowakMABonhoefferSEvolution and emergence of infectious diseases in theoretical and real-world networksNat Commun20156610125592476
  • JonesKEPatelNGLevyMAGlobal trends in emerging infectious diseasesNature2008451718199099318288193
  • FuxCACostertonJWStewartPSStoodleyPSurvival strategies of infectious biofilmsTrends Microbiol2005131344015639630
  • AparnaMSYadavSBiofilms: microbes and diseaseBraz J Infect Dis200812652653019287843
  • BjarnsholtTThe role of bacterial biofilms in chronic infectionsAPMIS201312113615823030626
  • BurmølleMRenDBjarnsholtTSørensenSJInteractions in multispecies biofilms: do they actually matter?Trends Microbiol2014222849124440178
  • CostertonJWLewandowskiZCaldwellDEKorberDRLappin-ScottHMMicrobial biofilmsAnnu Rev Microbiol1995497117458561477
  • FlemmingHCWingenderJThe biofilm matrixNat Rev Microbiol20108962363320676145
  • XavierJBPicioreanuCAlmeidaJSvan LoosdrechtMCMMonitorização e modelação da estrutura de biofilmes [Monitoring and modeling of biofilm structure]Bol Biotecnol2003761213 Portuguese [with English abstract]
  • D’AcuntoBFrunzoLKlapperIMatteiMRModeling multispecies biofilms including new bacterial species invasionMath Biosci2015259202625447810
  • AlmeidaMANDe FrançaFPBiofilm formation on brass coupons exposed to a cooling system of an oil refineryJ Ind Microbiol Biotechnol19982013944
  • PercivalSLKnappJSEdyveanRGJWalesDSBiofilms, mains water and stainless steelWater Res199832721872201
  • PercivalSLImportance of biofilm formation in surgical infectionBr J Surg20171042e85e9428121033
  • MyszkaKCzaczykKBacterial biofilms on food contact surfaces – a reviewPol J Food Nutr Sci2011613173180
  • WilkinsMHall-StoodleyLAllanRNFaustSNNew approaches to the treatment of biofilm-related infectionsJ Infect201469Suppl 1S47S5225240819
  • O’TooleGKaplanHBKolterRBiofilm formation as microbial developmentAnnu Rev Microbiol2000541497911018124
  • Castro-RosasJEscartínEFIncreased tolerance of Vibrio cholerae O1 to temperature, pH, or drying associated with colonization of shrimp carapacesInt J Food Microbiol2005102219520115992618
  • SimõesMAntimicrobial strategies effective against infectious bacterial biofilmsCurr Med Chem201118142129214521517762
  • BlackledgeMSWorthingtonRJMelanderCBiologically inspired strategies for combating bacterial biofilmsCurr Opin Pharmacol201313569970623871261
  • DaviesDUnderstanding biofilm resistance to antibacterial agentsNat Rev Drug Discov20032211412212563302
  • DunneWMJrBacterial adhesion: seen any good biofilms lately?Clin Microbiol Rev200215215516611932228
  • FriedlanderRSVlamakisHKimPKhanMKolterRAizenbergJBacterial flagella explore microscale hummocks and hollows to increase adhesionProc Natl Acad Sci U S A2013110145624562923509269
  • Hall-StoodleyLCostertonJWStoodleyPBacterial biofilms: from the natural environment to infectious diseasesNat Rev Microbiol2004229510815040259
  • HarsheyRMBacterial motility on a surface: many ways to a common goalAnnu Rev Microbiol200357124927314527279
  • HölscherTBartelsBLinYCMotility, chemotaxis and aerotaxis contribute to competitiveness during bacterial pellicle biofilm developmentJ Mol Biol2015427233695370826122431
  • PavithraDDobleMBiofilm formation, bacterial adhesion and host response on polymeric implants – issues and preventionBiomed Mater20083303400318689922
  • BurrowsLLPseudomonas aeruginosa twitching motility: type IV pili in actionAnnu Rev Microbiol201266149352022746331
  • PersatANadellCDKimMKThe mechanical world of bacteriaCell2015161598899726000479
  • RochfordETRichardsRGMoriartyTFInfluence of material on the development of device-associated infectionsClin Microbiol Infect201218121162116722925523
  • HodgkinsonAJCarpenterEASmithCSMolanPCProsserCGAdhesion molecule expression in the bovine mammary glandVet Immunol Immunopathol20071153–420521517173979
  • TrentinDDSGiordaniRBMacedoAJBiofilmes bacterianos patogênicos: aspectos gerais, importância clínica e estratégias de combate [Pathogenic bacterial biofilms: general aspects, clinical importance, and combat strategies]Rev Lib20131422113238 Portuguese [with English abstract]
  • LynchASRobertsonGTBacterial and fungal biofilm infectionsAnnu Rev Med200859141542817937586
  • RenduelesOGhigoJMMulti-species biofilms: how to avoid unfriendly neighborsFEMS Microbiol Rev201236597298922273363
  • DickschatJSQuorum sensing and bacterial biofilmsNat Prod Rep201027334336920179876
  • WonnenbergBTschernigTVossMProbenecid reduces infection and inflammation in acute Pseudomonas aeruginosa pneumoniaInt J Med Microbiol20143045–672572924938792
  • UlettGCTotsikaMSchaaleKCareyAJSweetMJSchembriMAUropathogenic Escherichia coli virulence and innate immune responses during urinary tract infectionCurr Opin Microbiol201316110010723403118
  • OjhaAKHatfullGFBiofilms of Mycobacterium tuberculosis: new perspectives of an old pathogenCardonaPere-JoanUnderstanding Tuberculosis – Deciphering the Secret Life of the BacilliInTech2012182192
  • ChenLWenYMThe role of bacterial biofilm in persistent infections and control strategiesInt J Oral Sci201132667321485310
  • MarrieTJNelliganJCostertonJWA scanning and transmission electron microscopic study of an infected endocardial pacemaker leadCirculation1982666133913417139907
  • RybtkeMHultqvistLDGivskovMTolker-NielsenTPseudomonas aeruginosa biofilm infections: community structure, antimicrobial tolerance and immune responseJ Mol Biol2015427233628364526319792
  • HirshDSBloomHLClinical use of antibacterial mesh envelopes in cardiovascular electronic device implantationsMed Devices (Auckl)20158717825624774
  • BaddourLMEpsteinAEEricksonCCAmerican Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease CommitteeCouncil on Cardiovascular Disease in YoungCouncil on Cardiovascular Surgery and AnesthesiaCouncil on Cardiovascular NursingCouncil on Clinical CardiologyInterdisciplinary Council on Quality of CareAmerican Heart AssociationUpdate on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart AssociationCirculation2010121345847720048212
  • MadhavanMSohailMRFriedmanPAMayo Cardiovascular Infections Study GroupOutcomes in patients with cardiovascular implantable electronic devices and bacteremia caused by Gram-positive cocci other than Staphylococcus aureusCirc Arrhythm Electrophysiol20103663964520852296
  • BruunNEHabibGThunyFSogaardPCardiac imaging in infectious endocarditisEur Heart J2014351062463223900698
  • LinTIHuangYFLiuPYPseudomonas aeruginosa infective endocarditis in patients who do not use intravenous drugs: analysis of risk factors and treatment outcomesJ Microbiol Immunol Infect201649451652225442867
  • YoonSSHenniganRFHilliardGMPseudomonas aeruginosa anaerobic respiration in biofilms: relationships to cystic fibrosis pathogenesisDev Cell20023459360312408810
  • CohenTSPrinceACystic fibrosis: a mucosal immunodeficiency syndromeNat Med201218450951922481418
  • GjødsbølKChristensenJJKarlsmarkTJørgensenBKleinBMKrogfeltKAMultiple bacterial species reside in chronic wounds: a longitudinal studyInt Wound J20063322523116984578
  • FazliMBjarnsholtTKirketerp-MøllerKQuantitative analysis of the cellular inflammatory response against biofilm bacteria in chronic woundsWound Repair Regen201119338739121518086
  • da SilvaPBRamosMABonifácioBVNanotechnological strategies for vaginal administration of drugs–a reviewJ Biomed Nanotechnol20141092218224325992455
  • GaydosCABarnesMAumakhanBChlamydia trachomatis age-specific prevalence in women who used an internet-based self-screening program compared to women who were screened in family planning clinicsSex Transm Dis2011382747821173720
  • WessmanMBjarnsholtTEickhardt-SørensenSRJohansenHKHomøePMucosal biofilm detection in chronic otitis media: a study of middle ear biopsies from Greenlandic patientsEur Arch Otorhinolaryngol201527251079108524477340
  • NgCGLokeMFGohKLVadiveluJHoBBiofilm formation enhances Helicobacter pylori survivability in vegetablesFood Microbiol201762687627889168
  • SgourasDNTrangTTHYamaokaYPathogenesis of Helicobacter pylori infectionHelicobacter20152081626372819
  • MonnoRFumarolaLCapolongoCSusceptibility of Helicobacter pylori to antibiotics including tigecyclineJ Med Microbiol Diagn2015S5005
  • YoonBIKimSHanDSAcute bacterial prostatitis: how to prevent and manage chronic infection?J Infect Chemother201218444445022215226
  • WagenlehnerFMPilatzABschleipferTBacterial prostatitisWorld J Urol201331471171623519458
  • ZumsteinVBetschartPAlbrichWCBiofilm formation on ureteral stents – incidence, clinical impact and preventionSwiss Med Wkly2017147w1440828165539
  • SinghRShivaprakashMRChakrabartiABiofilm formation by zygomycetes: quantification, structure and matrix compositionMicrobiology2011157Pt 92611261821636650
  • RizzelloLCingolaniRPompaPPNanotechnology tools for antibacterial materialsNanomedicine (Lond)20138580782123656266
  • ChengLZhangKWeirMDMeloMAZhouXXuHHNanotechnology strategies for antibacterial and remineralizing composites and adhesives to tackle dental cariesNanomedicine (Lond)201510462764125723095
  • HabimanaOSemiãoAJCCaseyEThe role of cell-surface interactions in bacterial initial adhesion and consequent biofilm formation of nanofiltration/reverse osmosis membranesJ Membr Sci20144548296
  • GarrettTRBhakooMZhangZBacterial adhesion and biofilms on surfacesProg Nat Sci200818910491056
  • AntasPRBritoMMPeixotoÉPonteCGBorbaCMNeglected and emerging fungal infections: review of hyalohyphomycosis by Paecilomyces lilacinus focusing in disease burden, in vitro antifungal susceptibility and managementMicrobes Infect20121411821907304
  • MayerFLWilsonDHubeBCandida albicans pathogenicity mechanismsVirulence20134211912823302789
  • NettJEAndesDRFungal biofilms: in vivo models for discovery of anti-biofilm drugsGhannoumMParsekMWhiteleyMMukherjeePMicrobial Biofilms2nd ed3Washington, DCASM Press20153349
  • YanagisawaNLiDQLjunghAProtein adsorption on ex vivo catheters and polymers exposed to peritoneal dialysis effluentPerit Dial Int200424326427315185775
  • HerwaldSEKumamotoCACandida albicans niche specialization: features that distinguish biofilm cells from commensal cellsCurr Fungal Infect Rep20148217918424839528
  • DouglasLJCandida biofilms and their role in infectionTrends Micro-biol20031113036
  • KojicEMDarouicheROCandida infections of medical devicesClin Microbiol Rev200417225526715084500
  • DesaiJVMitchellAPAndesDRFungal biofilms, drug resistance, and recurrent infectionCold Spring Harb Perspect Med2014410a01972925274758
  • ChandraJMukherjeePKGhannoumMACandida biofilms associated with CVC and medical devicesMycoses201255Suppl 14657
  • RamageGMowatEJonesBWilliamsCLopez-RibotJOur current understanding of fungal biofilmsCrit Rev Microbiol200935434035519863383
  • VelegrakiACafarchiaCGaitanisGIattaRBoekhoutTMalassezia infections in humans and animals: pathophysiology, detection, and treatmentPLoS Pathog2015111e100452325569140
  • CushionMTCollinsMSLinkeMJBiofilm formation by Pneumocystis sppEukaryot Cell20098219720618820078
  • Carreto-BinaghiLEDamascenoLSPitangui NdeSCould Histoplasma capsulatum be related to healthcare-associated infections?Biomed Res Int2015201598242926106622
  • MartinezLRCasadevallABiofilm formation by Cryptococcus neoformansGhannoumMAParsekMWhiteleyMMukherjeePKMicrobial Biofilms2nd edWashington, DCASM Press2015135147
  • GibsonJFJohnstonSAImmunity to Cryptococcus neoformans and C. gattii during cryptococcosisFungal Genet Biol201578768625498576
  • RamageGRajendranRSherryLWilliamsCFungal biofilm resistanceInt J Microbiol2012201252852122518145
  • MiceliMHDíazJALeeSAEmerging opportunistic yeast infectionsLancet Infect Dis201111214215121272794
  • MitchellKFZarnowskiRSanchezHCommunity participation in biofilm matrix assembly and functionProc Natl Acad Sci U S A2015112134092409725770218
  • TsangPWBandaraHMFongWPPurpurin suppresses Candida albicans biofilm formation and hyphal developmentPLoS One2012711e5086623226409
  • SilvaSNegriMHenriquesMOliveiraRWilliamsDWAzeredoJCandida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistanceFEMS Microbiol Rev201236228830521569057
  • VylkovaSLorenzMCModulation of Phagosomal pH by Candida albicans promotes hyphal morphogenesis and requires Stp2p, a regulator of amino acid transportPLoS Pathog2014103e100399524626429
  • HardingMWMarquesLLHowardRJOlsonMECan filamentous fungi form biofilms?Trends Microbiol2009171147548019833519
  • EnjalbertBWhitewayMRelease from quorum-sensing molecules triggers hyphal formation during Candida albicans resumption of growthEukaryot Cell2005471203121016002646
  • HornbyJMJensenECLisecADQuorum sensing in the dimorphic fungus Candida albicans is mediated by farnesolAppl Environ Microbiol20016772982299211425711
  • SemighiniCPHornbyJMDumitruRNickersonKWHarrisSDFarnesol-induced apoptosis in Aspergillus nidulans reveals a possible mechanism for antagonistic interactions between fungiMol Microbiol200659375376416420349
  • ScheperMAShirtliffMEMeillerTFPetersBMJabra-RizkMAFarnesol, a fungal quorum-sensing molecule triggers apoptosis in human oral squamous carcinoma cellsNeoplasia200810995496318714396
  • DichtlKEbelFDirrFRoutierFHHeesemannJWagenerJFarnesol misplaces tiplocalized Rho proteins and inhibits cell wall integrity signalling in Aspergillus fumigatusMol Microbiol20107651191120420398212
  • SharmaMPrasadRThe quorum-sensing molecule farnesol is a modulator of drug efflux mediated by ABC multidrug transporters and synergizes with drugs in Candida albicansAntimicrob Agents Chemother201155104834484321768514
  • LeonhardtISpielbergSWeberMThe fungal quorum-sensing molecule farnesol activates innate immune cells but suppresses cellular adaptive immunityMBio201562e0014325784697
  • ChenHFujitaMFengQClardyJFinkGRTyrosol is a quorum-sensing molecule in Candida albicansProc Natl Acad Sci U S A2004101145048505215051880
  • HarriottMMLillyEARodriguezTEFidelPLNoverrMCCandida albicans forms biofilms on the vaginal mucosaMicrobiology2010156Pt 123635364420705667
  • NobileCJJohnsonADCandida albicans biofilms and human diseaseAnnu Rev Microbiol2015691719226488273
  • PappasPGInvasive candidiasisInfect Dis Clin North Am200620348550616984866
  • CampionEWKullbergBJArendrupMCInvasive candidiasisN Engl J Med2015373151445145626444731
  • Sardi JdeCPitangui NdeSRodríguez-ArellanesGTaylorMLFusco-AlmeidaAMMendes-GianniniMJHighlights in pathogenic fungal biofilmsRev Iberoam Micol2014311222924252828
  • CaggianoGCorettiCBartolomeoNLoveroGDe GiglioOMontagnaMTCandida bloodstream infections in Italy: changing epidemiology during 16 years of surveillanceBiomed Res Int2015201525658026064890
  • RongpharpiSRGurRDuggalSCandida krusei fungemia in 7 neonates: clonality tracked to an infusateAm J Infect Control201442111247124825444273
  • SpanakisEKAperisGMylonakisENew agents for the treatment of fungal infections: clinical efficacy and gaps in coverageClin Infect Dis20064381060106816983621
  • SobelJDRecurrent vulvovaginal candidiasisAm J Obstet Gynecol20162141152126164695
  • GemmillJAStrattonPClearySDBallwegMLSinaiiNCancers, infections, and endocrine diseases in women with endometriosisFertil Steril20109451627163119945097
  • AulerMEMorreiraDRodriguesFFBiofilm formation on intrauterine devices in patients with recurrent vulvovaginal candidiasisMed Mycol201048121121620055746
  • AderFInvasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: an emerging fungal diseaseCurr Infect Dis Rep201012640941621308548
  • DimopoulosGFrantzeskakiFPoulakouGArmaganidisAInvasive aspergillosis in the intensive care unitAnn N Y Acad Sci201212721313923231712
  • BakareNRickertsVBargonJJust-NüblingGPrevalence of Aspergillus fumigatus and other fungal species in the sputum of adult patients with cystic fibrosisMycoses2003461–21923
  • BohseMLWoodsJPRNA interference-mediated silencing of the YPS3 gene of Histoplasma capsulatum reveals virulence defectsInfect Immun20077562811281717403872
  • Suárez-AlvarezROPérez-TorresATaylorMLAdherence patterns of Histoplasma capsulatum yeasts to bat tissue sectionsMycopathologia20101702798720340046
  • PitanguiNSSardiJCSilvaJFAdhesion of Histoplasma capsulatum to pneumocytes and biofilm formation on an abiotic surfaceBiofouling201228771171822784100
  • Martin-GarridoICarmonaEMSpecksULimperAHPneumocystis pneumonia in patients treated with rituximabChest2013144125826523258406
  • HuangLCattamanchiADavisJLInternational HIV-associated Opportunistic Pneumonias (IHOP) StudyLung HIV StudyHIV-associated Pneumocystis pneumoniaProc Am Thorac Soc20118329430021653531
  • ChayakulkeereeMPerfectJRCryptococcosisInfect Dis Clin North Am2006203507544vvi16984867
  • HernándezYUMonzónJFDelgado-HernándezRSoto-HernándezJLCárdenasGCryptococcoma of the brain in an immunocompetent manNatl Med J India201326421621724758445
  • LiaoYLuXYangSLuoYChenQYangREpidemiology and outcome of Trichosporon fungemia: a review of 185 reported cases from 1975 to 2014Open Forum Infect Dis201524 Epub925
  • Iturrieta-GonzálezIAPadovanACBizerraFCHahnRCColomboALMultiple species of Trichosporon produce biofilms highly resistant to triazoles and amphotericin BPLoS One2014910e10955325360765
  • de PaviaFagundesJúniorAAde CarvalhoRTFocacciaREmergência de infecção por Trichosporon Asahii em pacientes portadores de insuficiência cardíaca em unidade de terapia intensiva cardiológica: relato de caso e revisão da literatura [Trichosporon asahii an emerging etiologic agent of fungal infection and colonization in heart failure patients in intensive care unit: case report and literature review]Rev Bras Ter Intensiva2008201106109 Portuguese [with English abstract]25306958
  • MattedeMGSPirasCMattedeKDSFerrariATBaldottoLSAssbuMSZUrinary tract infections due to Trichosporon spp. in severely ill patients in an intensive care unitRev Bras Ter Intensiva201527324725126465246
  • RömlingUBalsalobreCBiofilm infections, their resilience to therapy and innovative treatment strategiesJ Intern Med2012272654156123025745
  • RömlingUKjellebergSNormarkSNymanLUhlinBEÅkerlundBMicrobial biofilm formation: a need to actJ Intern Med201427629811024796496
  • DiciccoMNeethirajanSSinghAWeeseJSEfficacy of clarithro-mycin on biofilm formation of methicillin-resistant Staphylococcus pseudintermediusBMC Vet Res2012822523171620
  • De OliveiraMMMBrugneraDFPicolliRHBiofilmes microbianos na indústria de alimentos: uma revisão [Microbial biofilms in the food industry: a review]Rev Inst Adolfo Lutz2010693277284 Portuguese [with English abstract]
  • GilbertPAllisonDGMcBainAJBiofilms in vitro and in vivo: do singular mechanisms imply cross-resistance?J Appl Microbiol200292Suppl98S110S12000619
  • RomaníAMFundKArtigasJSchwartzTSabaterSObstURelevance of polymeric matrix enzymes during biofilm formationMicrob Ecol200856342743618227962
  • YangYLChenMGuJLCryptococcosis in kidney transplant recipients in a Chinese university hospital and a review of published casesInt J Infect Dis20142615416125063020
  • HøibyNCiofuOJohansenHKThe clinical impact of bacterial biofilmsInt J Oral Sci201132556521485309
  • SmithAWBiofilms and antibiotic therapy: is there a role for combating bacterial resistance by the use of novel drug delivery systems?Adv Drug Deliv Rev200557101539155015950314
  • SotoSMRole of efflux pumps in the antibiotic resistance of bacteria embedded in a biofilmVirulence20134322322923380871
  • MahTFBiofilm-specific antibiotic resistanceFuture Microbiol2012791061107222953707
  • PodneckyNLRhodesKASchweizerHPEfflux pump-mediated drug resistance in BurkholderiaFront Microbiol2015630525926825
  • SchlisselbergDBKlerEKislukGShacharDYaronSBiofilm formation ability of Salmonella enterica serovar Typhimurium acrAB mutantsInt J Antimicrob Agents201546445645926260191
  • GillisRJWhiteKGChoiK-HWagnerVESchweizerHPIglewskiBHMolecular basis of azithromycin-resistant Pseudomonas aeruginosa biofilmsAntimicrob Agents Chemother20054993858386716127063
  • Van AckerHVan DijckPCoenyeTMolecular mechanisms of antimicrobial tolerance and resistance in bacterial and fungal biofilmsTrends Microbiol201422632633324598086
  • PrasadRGoffeauAYeast ATP-binding cassette transporters conferring multidrug resistanceAnnu Rev Microbiol2012661396322703054
  • MateusCCrowSAJrAhearnDGAdherence of Candida albicans to silicone induces immediate enhanced tolerance to fluconazoleAntimicrob Agents Chemother20044893358336615328097
  • TanAChawlaRGNNanotechnology and regenerative therapeutics in plastic surgery: the next frontierJ Plast Reconstr Aesthet Surg201669111326422652
  • LinTCHungKHPengCHNanotechnology-based drug delivery treatments and specific targeting therapy for age-related macular degenerationJ Chin Med Assoc2015781163564126383186
  • BarkalinaNCharalambousCJonesCCowardKNanotechnology in reproductive medicine: emerging applications of nanomaterialsNanomedicine201410592193824444494
  • BharaliDJSiddiquiIAAdhamiVMNanoparticle delivery of natural products in the prevention and treatment of cancers: current status and future prospectsCancers (Basel)2011344024404524213123
  • PelgriftRYFriedmanAJNanotechnology as a therapeutic tool to combat microbial resistanceAdv Drug Deliv Rev20136513–141803181523892192
  • MartinCLowWLGuptaAStrategies for antimicrobial drug delivery to biofilmCurr Pharm Des2015211436625189862
  • ForierKRaemdonckKDe SmedtSCDemeesterJCoenyeTBraeckmansKLipid and polymer nanoparticles for drug delivery to bacterial biofilmsJ Control Release201419060762324794896
  • SinghRNadheSWadhwaniSShedbalkarUChopadeBANanoparticles for control of biofilms of Acinetobacter speciesMaterials (Basel)201695E38328773507
  • Al-JamalWTKostarelosKLiposomes: from a clinically established drug delivery system to a nanoparticle platform for theranostic nanomedicineAcc Chem Res201144101094110421812415
  • AkbarzadehARezaei-SadabadyRDavaranSLiposome: classification, preparation, and applicationsNanoscale Res Lett20138110223432972
  • AhmedKMuiruriPWJonesGHScottMJJonesMNThe effect of grafted poly(ethylene glycol) on the electrophoretic properties of phospholipid liposomes and their adsorption to bacterial biofilmsColloids Surf A Physicochem Eng Asp20011941–3287296
  • RobinsonAMBannisterMCreethJEJonesMNThe interaction of phospholipid liposomes with mixed bacterial biofilms and their use in the delivery of bactericideColloids Surf A Physicochem Eng Asp20011861–24353
  • CatuognoCJonesMNThe antibacterial properties of solid supported liposomes on Streptococcus oralis biofilmsInt J Pharm20032571–212514012711168
  • Drulis-KawaZDorotkiewicz-JachAGubernatorJGulaGBocerTDoroszkiewiczWThe interaction between Pseudomonas aeruginosa cells and cationic PC:Chol:DOTAP liposomal vesicles versus outer-membrane structure and envelope properties of bacterial cellInt J Pharm20093671–221121918952159
  • GubernatorJDrulis-KawaZDorotkiewicz-JachADoroskiewieczWKozubekAIn vitro antimicrobial activity of liposomes containing ciprofloxacin, meropenem and gentamicin against gram-negative clinical bacterial strainsLett Drug Des Discov200744297304
  • OmriASuntresZEShekPNEnhanced activity of liposomal polymyxin B against Pseudomonas aeruginosa in a rat model of lung infectionBiochem Pharmacol20026491407141312392822
  • RukholmGMugabeCAzghaniAOOmriAAntibacterial activity of liposomal gentamicin against Pseudomonas aeruginosa: a time-kill studyInt J Antimicrob Agents200627324725216472992
  • MugabeCAzghaniAOOmriALiposome-mediated gentamicin delivery: development and activity against resistant strains of Pseudomonas aeruginosa isolated from cystic fibrosis patientsJ Antimicrob Chemother200555226927115590716
  • AlipourMSuntresZEOmriAImportance of DNase and alginate lyase for enhancing free and liposome encapsulated aminoglycoside activity against Pseudomonas aeruginosaJ Antimicrob Chemother200964231732519465435
  • AlhajlanMAlhaririMOmriAEfficacy and safety of liposomal clarithromycin and its effect on Pseudomonas aeruginosa virulence factorsAntimicrob Agents Chemother20135762694270423545534
  • AlipourMHalwaniMOmriASuntresZEAntimicrobial effectiveness of liposomal polymyxin B against resistant Gram-negative bacterial strainsInt J Pharm20083551–229329818164881
  • AlipourMSuntresZELafrenieRMOmriAAttenuation of Pseudomonas aeruginosa virulence factors and biofilms by co-encapsulation of bismuth-ethanedithiol with tobramycin in liposomesJ Antimicrob Chemother201065468469320159770
  • BonifácioBVSilvaPBRamosMANegriKMBauabTMChorilliMNanotechnology-based drug delivery systems and herbal medicines: a reviewInt J Nanomedicine20139111524363556
  • RyanRAltriaKMcEvoyEDoneganSPowerJA review of developments in the methodology and application of microemulsion electrokinetic chromatographyElectrophoresis201334115917723161220
  • LawrenceMJReesGDMicroemulsion-based media as novel drug delivery systemsAdv Drug Deliv Rev20004518912111104900
  • MuzaffarFSinghUKChauhanLReview on microemulsion as futuristic drug deliveryInt J Pharm Pharm Sci2013533953
  • Al-AdhamISAshourHAl-KaissiEKhalilEKieransMCollierPJStudies on the kinetics of killing and the proposed mechanism of action of microemulsions against fungiInt J Pharm2013454122623223830945
  • SinghPKKashif IqubalMShuklaVKShuaibMMicroemulsions: current trends in novel drug delivery systemsJ Pharm Chem Biol Sci2014113951
  • MishraAPanolaRRanaACMicroemulsions: as drug delivery systemJ Sci Innov Res201434467474
  • HungCFFangCLLiaoMHFangJYThe effect of oil components on the physicochemical properties and drug delivery of emulsions: tocol emulsion versus lipid emulsionInt J Pharm20073351–219320217129692
  • AntonNVandammeTFNano-emulsions and micro-emulsions: clarifications of the critical differencesPharm Res201128597898521057856
  • BruxelFLauxMWildLBFragaMKoesterLSTexeiraHFNanoemulsão como sistemas de liberação parenteral de fármacos [Nanoemulsions as parenteral drug delivery systems]Quim Nova201235918271840 Portuguese [with English asbtract]
  • RamalingamKAmaechiBTRalphRHLeeVAAntimicrobial activity of nanoemulsion on cariogenic planktonic and biofilm organismsArch Oral Biol2012571152221807359
  • RamalingamKFrohlichNCLeeVAEffect of nanoemulsion on dental unit waterline biofilmJ Dent Sci201383333336
  • TeixeiraPCLeiteGMDominguesRJSilvaJGibbsPAFerreiraJPAntimicrobial effects of a microemulsion and a nanoemulsion on enteric and other pathogens and biofilmsInt J Food Microbiol20071181151917610974
  • LiuCHHuangHYAntimicrobial activity of curcumin-loaded myristic acid microemulsions against Staphylococcus epidermidisChem Pharm Bull (Tokyo)20126091118112422976319
  • Al-AdhamISAl-HmoudNDKhalilEKieransMCollierPJMicroemulsions are highly effective anti-biofilm agentsLett Appl Microbiol20033629710012535129
  • VilliersASur la fermentation de la fécule par l’action du ferment butyrique [The fermentation of starch by the action of butyric]Compt Rend Acad Sci1891112536538 French [with English abstract]
  • ZhangJMaPXCyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspectiveAdv Drug Deliv Rev20136591215123323673149
  • Morin-CriniNCriniGEnvironmental applications of water-insoluble β-cyclodextrin–epichlorohydrin polymersProg Polym Sci2013382344368
  • MartinsMRFMVeigaFPromotores de permeação para a liberação transdérmica de fármacos: uma nova aplicação para as ciclodextrinas [Permeation promoters for transdermal drug delivery: a new application for cyclodextrins]Rev Bras Ciênc Farm20023813354 Portuguese [with English abstract]
  • GharbiAHumblotVTurpinFPradierCMImbertCBerjeaudJMElaboration of antibiofilm surfaces functionalized with antifungal-cyclodextrin inclusion complexesFEMS Immunol Med Microbiol201265225726922268719
  • SzenteLSzemánJSohajdaTAnalytical characterization of cyclo-dextrins: history, official methods and recommended new techniquesJ Pharm Biomed Anal201613034736527246683
  • Acuña-RougierCOlea-AzarCThermodynamic and geometric study of diasteroisomeric complexes formed by racemic flavanones and three cyclodextrins through NMRJ Incl Phenom Macrocycl Chem2013751–2119136
  • Folch-CanoCYazdani-PedramMOlea-AzarCInclusion and func-tionalization of polymers with cyclodextrins: current applications and future prospectsMolecules2014199140661407925207713
  • Otero-EspinarFJTorres-LabandeiraJJAlvarez-LorenzoCBlanco-MéndezJCyclodextrins in drug delivery systemsJ Drug Deliv Sci Technol2010204289301
  • LakkakulaJRMaçedo KrauseRWA vision for cyclodextrin nano-particles in drug delivery systems and pharmaceutical applicationsNanomedicine (Lond)20149687789424981652
  • LoftssonTDucheneDCyclodextrins and their pharmaceutical applicationsInt J Pharm20073291–211117137734
  • MatsudaHArimaHCyclodextrins in transdermal and rectal deliveryAdv Drug Deliv Rev1999361819910837710
  • PinhoEGrootveldMSoaresGHenriquesMCyclodextrins as encapsulation agents for plant bioactive compoundsCarbohydr Polym201410112113524299757
  • LulaIDenadaiÂLResendeJMStudy of angiotensin-(1–7) vasoactive peptide and its β-cyclodextrin inclusion complexes: complete sequence-specific NMR assignments and structural studiesPeptides200728112199221017904691
  • CortésMEBonillaJCSinisterraRDBiofilm formation, control and novel strategies for eradicationMendez-VilasAScience Against Microbial Pathogens: Communicating Current Research and Technological AdvancesBadajozFormatex Research Center2011896905
  • HealingGSulemannTCottonPSafety data on 19 vehicles for use in 1 month oral rodent pre-clinical studies: administration of hydroxypropyl-β-cyclodextrin causes renal toxicityJ Appl Toxicol201636114015025959454
  • SuvarnaVGujarPMurahariMComplexation of phytochemicals with cyclodextrin derivatives – an insightBiomed Pharmacother2017881122114428208574
  • GharibRGreige-GergesHFourmentinSCharcossetCAuezovaLLiposomes incorporating cyclodextrin-drug inclusion complexes: current state of knowledgeCarbohydr Polym201512917518626050903
  • HolmROlesenNEHartvigRAJørgensenEBLarsenDBWesthPEffect of cyclodextrin concentration on the oral bioavailability of danazol and cinnarizine in ratsEur J Pharm Biopharm201610191426776271
  • TrottaFDianzaniCCalderaFMognettiBCavalliRThe application of nanosponges to cancer drug deliveryExpert Opin Drug Deliv201411693194124811423
  • FreiresIDAMurataRMFurlettiVFCoriandrum sativum L. (Coriander) essential oil: antifungal activity and mode of action on Candida spp., and molecular targets affected in human whole-genome expressionPLoS One201496e9908624901768
  • HusainFMAhmadIKhanMSSub-MICs of Mentha piperita essential oil and menthol inhibits AHL mediated quorum sensing and biofilm of Gram-negative bacteriaFront Microbiol2015642026029178
  • AzzimontiBCochisABeyrouthyMEEssential oil from berries of lebanese Juniperus excelsa M. Bieb displays similar antibacterial activity to chlorhexidine but higher cytocompatibility with human oral primary cellsMolecules20152059344935726007187
  • dos SantosJFTorres-LabandeiraJJMatthijsNCoenyeTConcheiroAAlvarez-LorenzoCFunctionalization of acrylic hydrogels with α-, β- or γ-cyclodextrin modulates protein adsorption and antifungal deliveryActa Biomater20106103919392620417319
  • Garcia-FernandezMJBrackmanGCoenyeTConcheiroAAlvarez-LorenzoCAntiseptic cyclodextrin-functionalized hydrogels and gauzes for loading and delivery of benzalkonium chlorideBiofouling201329326127123439005
  • IordacheFGrumezescuVGrumezescuAMGamma-cyclodextrin/usnic acid thin film fabricated by MAPLE for improving the resistance of medical surfaces to Staphylococcus aureus colonizationAppl Surf Sci2015336407412
  • BrackmanGGarcia-FernandezMJLenoirJDressings loaded with cyclodextrin-hamamelitannin complexes increase Staphylococcus aureus susceptibility toward antibiotics both in single as well as in mixed biofilm communitiesMacromol Biosci201616685986926891369
  • FidaleoMZuorroALavecchiaREnhanced antibacterial and anti-quorum sensing activities of triclosan by complexation with modified β-cyclodextrinsWorld J Microbiol Biotechnol20132991731173623536199
  • AlayandeABKimLHKimISCleaning efficacy of hydroxypropyl-beta-cyclodextrin for biofouling reduction on reverse osmosis membranesBiofouling201632435937026923225
  • Shanmuga PriyaASivakamavalliJVaseeharanBStalinTImprovement on dissolution rate of inclusion complex of Rifabutin drug with β-cyclodextrinInt J Biol Macromol20136247248024076034
  • LoftssonTBrewsterMECyclodextrins as functional excipients: methods to enhance complexation efficiencyJ Pharm Sci201210193019303222334484
  • JaiswalSBhattacharyaKMcHalePDuffyBDual effects of β-cyclodextrin-stabilised silver nanoparticles: enhanced biofilm inhibition and reduced cytotoxicityJ Mater Sci Mater Med2015261536725596861
  • OpreaAEPandelLMDumitrescuAMBioactive ZnO coatings deposited by MAPLE–an appropriate strategy to produce efficient anti-biofilm surfacesMolecules2016212220
  • Nava-OrtizCABBurilloGConcheiroACyclodextrin-functionalized biomaterials loaded with miconazole prevent Candida albicans biofilm formation in vitroActa Biomater2010641398140419874920
  • RuizHKSerranoDRDea-AyuelaMANew amphotericin B-gamma cyclodextrin formulation for topical use with synergistic activity against diverse fungal species and Leishmania sppInt J Pharm20144731–214815724998510
  • EkambaramPSathaliAAHPriyankaKSolid lipid nanoparticles: a reviewSci Rev Chem Commun20122180102
  • SinghBBandyopadhyaySKapilRKatareOPNovel nanostructured lipidic drug delivery systemsPharma Rev2009742118122
  • SinghBVuddandaPRMRVKumarVSaxenaPSSinghSCefu-roxime axetil loaded solid lipid nanoparticles for enhanced activity against S. aureus biofilmColloids Surf B Biointerfaces2014121929824945607
  • NafeeNHusariAMaurerCKAntibiotic-free nanotherapeutics: ultra-small, mucus-penetrating solid lipid nanoparticles enhance the pulmonary delivery and anti-virulence efficacy of novel quorum sensing inhibitorsJ Control Release201419213114024997276
  • TaylorENKummerKMDyondiDWebsterTJBanerjeeRMulti-scale strategy to eradicate Pseudomonas aeruginosa on surfaces using solid lipid nanoparticles loaded with free fatty acidsNanoscale20146282583224264141
  • Quintanar-GuerreroDAllémannEDoelkerEFessiHPreparation and characterization of nanocapsules from preformed polymers by a new process based on emulsification-diffusion techniquePharm Res1998157105610629688060
  • SchaffazickSRGuterresSSCaracterização e estabilidade físico-química de sistemas poliméricos nanoparticulados para administração de fármacos [Characterization and physico-chemical stability of nanoparticulate polymer systems for administration of drugs]Quim Nova2006265726737 Portuguese [with English abstract]
  • PlapiedLDuhemNdes RieuxAPréatVFate of polymeric nanocarriers for oral drug deliveryCurr Opin Colloid Interface Sci2011163228237
  • ReisCPNeufeldRJRibeiroAJVeigaFNanoencapsulation I. Methods for preparation of drug-loaded polymeric nanoparticlesNanomedicine20062182117292111
  • ShafferCNanomedicine transforms drug deliveryDrug Discov Today20051023–2415811582
  • Da SilvaLFinerYFriedmanSBasraniBKishenABiofilm formation within the interface of bovine root dentin treated with conjugated chitosan and sealer containing chitosan nanoparticlesJ Endod201339224925323321239
  • AbdelghanySMQuinnDJIngramRJGentamicin-loaded nano-particles show improved antimicrobial effects towards Pseudomonas aeruginosa infectionInt J Nanomedicine201274053406322915848
  • CaiJHuangHSongWPreparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitroInt J Pharm2015495272873726417849
  • TakahashiCOgawaNKawashimaYYamamotoHObservation of antibacterial effect of biodegradable polymeric nanoparticles on Staphylococcus epidermidis biofilm using FE-SEM with an ionic liquidMicroscopy (Oxf)201564316918025757698
  • FaradayMThe Bakerian lecture: experimental relations of gold (and other metals) to lightPhilos Trans R Soc Lond1857147145181
  • HorvathHGustav Mie and the scattering and absorption of light by particles: historic developments and basicsJ Quant Spectrosc Radiat Transf200911011787799
  • MeloMAJrSantosLSSGonçalves M doCNogueiraAFPreparação de nanopartículas de prata e ouro: um método simples para a introdução da nanociência em laboratório de ensino [Preparation of silver and gold nanoparticles: a simple method to introduce nanotechnology into teaching laboratories]Quím Nova201235918721878 Portuguese [with English abstract]
  • KlabundeKJFrontmatter and index Nanoscale Materials in ChemistryNew YorkJohn Wiley & Sons, Inc2001ixi
  • KumarMVarshneyLFrancisSRadiolytic formation of Ag clusters in aqueous polyvinyl alcohol solution and hydrogel matrixRadiat Phys Chem20057312127
  • XuXLYinYDGeXWWuHKZhangZHγ-Radiation synthesis of poly(acrylic acid)–metal nanocompositesMater Lett199837354358
  • KhanSTAhamedMAl-KhedhairyAMusarratJBiocidal effect of copper and zinc oxide nanoparticles on human oral microbiome and biofilm formationMater Lett2013976770
  • KhanSTAhamedMMusarratJAl-KhedhairyAAAnti-biofilm and antibacterial activities of zinc oxide nanoparticles against the oral opportunistic pathogens Rothia dentocariosa and Rothia mucilaginosaEur J Oral Sci2014122639740325311638
  • SanganiMHMoghaddamMNForghanifardMMInhibitory effect of zinc oxide nanoparticles on pseudomonas aeruginosa biofilm formationNanomedicine J201522121128
  • DwivediSWahabRKhanFMishraYKMusarratJAl-KhedhairyAAReactive oxygen species mediated bacterial biofilm inhibition via zinc oxide nanoparticles and their statistical determinationPLoS One2014911e11128925402188
  • SeilJTWebsterTJReduced Staphylococcus aureus proliferation and biofilm formation on zinc oxide nanoparticle PVC composite surfacesActa Biomater2011762579258421421087
  • LeeJHKimYGChoMHLeeJZnO nanoparticles inhibit Pseudomonas aeruginosa biofilm formation and virulence factor productionMicrobiol Res20141691288889624958247
  • PrattLAKolterRGenetic analysis of Escherichia coli biofilm formation: roles of flagella, motility, chemotaxis and type I piliMol Microbiol19983022852939791174
  • HaghighiFMohammadiSRMohammadiPHosseinkhaniSAnti-fungal activity of TiO2 nanoparticles and EDTA on Candida albicans BiofilmsInfect Epidemiol Med2013113338
  • IbrahemKHSalmanJASAliFAEffect of titanium nanoparticles biosynthesis by Lactobacillus crispatus on urease, hemolysin & biofilm forming by some bacteria causing recurrent UTI in Iraqi womenEur Sci J2014109324338
  • Maurer-JonesMAGunsolusILMeyerBMChristensonCJHaynesCLImpact of TiO2 nanoparticles on growth, biofilm formation, and flavin secretion in Shewanella oneidensisAnal Chem201385125810581823701037
  • NamasivayamSKRChristoBBArasuSMKKumarKAMDeepakKAnti biofilm effect of biogenic silver nanoparticles coated medical devices against biofilm of clinical isolate of Staphylococcus aureusGlob J Med Res2013133 Epub624
  • ParkHParkSRohJBiofilm-inactivating activity of silver nanoparticles: a comparison with silver ionsJ Ind Eng Chem2013192614619
  • Martinez-GutierrezFBoegliLAgostinhoAAnti-biofilm activity of silver nanoparticles against different microorganismsBiofouling201329665166023731460
  • GurunathanSHanJWKwonDNKimJHEnhanced antibacterial and anti-biofilm activities of silver nanoparticles against Gram-negative and Gram-positive bacteriaNanoscale Res Lett20149137325136281
  • KalishwaralalKBarathManiKanthSPandianSRDeepakVGurunathanSSilver nanoparticles impede the biofilm formation by Pseudomonas aeruginosa and Staphylococcus epidermidisColloids Surf B Biointerfaces201079234034420493674
  • MonteiroDRTakamiyaASFeresinLPSusceptibility of Candida albicans and Candida glabrata biofilms to silver nanoparticles in intermediate and mature development phasesJ Prosthodont Res2015591424825168655
  • QinHCaoHZhaoYIn vitro and in vivo anti-biofilm effects of silver nanoparticles immobilized on titaniumBiomaterials201435339114912525112937
  • KhanSAlamFAzamAKhanAUGold nanoparticles enhance methylene blue-induced photodynamic therapy: a novel therapeutic approach to inhibit Candida albicans biofilmInt J Nanomedicine201273245325722802686
  • DuongHTTAdnanNNMBarraudNFunctional gold nano-particles for the storage and controlled release of nitric oxide: applications in biofilm dispersal and intracellular deliveryJ Mater Chem B201423150035011
  • BodaSKBrodaJSchieferFCytotoxicity of ultrasmall gold nanoparticles on planktonic and biofilm encapsulated gram-positive staphylococciSmall201511263183319325712910
  • SathyanarayananMBBalachandranathRGenji SrinivasuluYKannaiyanSKSubbiahdossGThe effect of gold and iron-oxide nanoparticles on biofilm-forming pathogensISRN Microbiol2013201327208624187645